Broadleaf Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.86M | Sell |
7,326
-400
| -5% | -$93.2K | 0.36% | 42 |
|
|
2026
Q1 | $1.89M | Buy |
7,726
+378
| +5% | +$88K | 0.44% | 44 |
|
|
2025
Q4 | $1.52M | Buy |
7,348
+43
| +0.6% | +$8.5K | 0.32% | 45 |
|
|
2025
Q3 | $1.35M | Buy |
7,305
+98
| +1% | +$16.8K | 0.28% | 44 |
|
|
2025
Q2 | $1.1M | Hold |
7,207
| – | – | 0.24% | 48 |
|
|
2025
Q1 | $1.2M | Sell |
7,207
-4
| -0.1% | -$626 | 0.31% | 48 |
|
|
2024
Q4 | $1.04M | Hold |
7,211
| – | – | 0.24% | 45 |
|
|
2024
Q3 | $1.17M | Hold |
7,211
| – | – | 0.28% | 44 |
|
|
2024
Q2 | $1.05M | Sell |
7,211
-5
| -0.1% | -$744 | 0.26% | 42 |
|
|
2024
Q1 | $1.14M | Hold |
7,216
| – | – | 0.29% | 45 |
|
|
2023
Q4 | $1.13M | Sell |
7,216
-7
| -0.1% | -$1.07K | 0.33% | 46 |
|
|
2023
Q3 | $1.12M | Hold |
7,223
| – | – | 0.38% | 40 |
|
|
2023
Q2 | $1.2M | Sell |
7,223
-8
| -0.1% | -$1.29K | 0.39% | 41 |
|
|
2023
Q1 | $1.12M | Sell |
7,231
-63
| -0.9% | -$10.2K | 0.4% | 42 |
|
|
2022
Q4 | $1.29M | Hold |
7,294
| – | – | 0.51% | 40 |
|
|
2022
Q3 | $1.19M | Sell |
7,294
-21
| -0.3% | -$3.55K | 0.5% | 40 |
|
|
2022
Q2 | $1.3M | Sell |
7,315
-50
| -0.7% | -$8.91K | 0.54% | 38 |
|
|
2022
Q1 | $1.3M | Hold |
7,365
| – | – | 0.43% | 41 |
|
|
2021
Q4 | $1.26M | Hold |
7,365
| – | – | 0.39% | 41 |
|
|
2021
Q3 | $1.19M | Hold |
7,365
| – | – | 0.39% | 44 |
|
|
2021
Q2 | $1.21M | Buy |
7,365
+130
| +2% | +$21.5K | 0.42% | 44 |
|
|
2021
Q1 | $1.19M | Sell |
7,235
-15
| -0.2% | -$2.43K | 0.45% | 43 |
|
|
2020
Q4 | $1.14M | Hold |
7,250
| – | – | 0.45% | 42 |
|
|
2020
Q3 | $1.08M | Hold |
7,250
| – | – | 0.48% | 42 |
|
|
2020
Q2 | $1.02M | Sell |
7,250
-22
| -0.3% | -$3.21K | 0.5% | 42 |
|
|
2020
Q1 | $954K | Buy |
7,272
+132
| +2% | +$18.7K | 0.61% | 40 |
|
|
2019
Q4 | $1.04M | Buy |
7,140
+936
| +15% | +$127K | 0.57% | 39 |
|
|
2019
Q3 | $803K | Sell |
6,204
-56
| -0.9% | -$7.38K | 0.5% | 40 |
|
|
2019
Q2 | $872K | Hold |
6,260
| – | – | 0.56% | 38 |
|
|
2019
Q1 | $875K | Sell |
6,260
-90
| -1% | -$12.1K | 0.61% | 37 |
|
|
2018
Q4 | $819K | Hold |
6,350
| – | – | 0.65% | 38 |
|
|
2018
Q3 | $877K | Sell |
6,350
-20
| -0.3% | -$2.66K | 0.59% | 41 |
|
|
2018
Q2 | $773K | Sell |
6,370
-27
| -0.4% | -$3.37K | 0.57% | 41 |
|
|
2018
Q1 | $820K | Hold |
6,397
| – | – | 0.63% | 38 |
|
|
2017
Q4 | $894K | Buy |
+6,397
| New | +$891K | 0.74% | 36 |
|
Other funds holding JNJ
Broadleaf Partners's JNJ Position: Q2 2026 in Review
Broadleaf Partners reduced its Johnson & Johnson (JNJ) stake by 5.2% in Q2 2026, selling an estimated $93.2K and leaving 7,326 shares worth $1.86M. The position accounts for 0.36% of the portfolio, ranked #42.
Broadleaf Partners first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.89M in Q1 2026. 4,686 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Broadleaf Partners held 7,326 shares of Johnson & Johnson worth $1.86M as of Q2 2026.
- Broadleaf Partners sold 400 Johnson & Johnson shares in Q2 2026, an estimated $93.2K.
- Johnson & Johnson made up 0.36% of Broadleaf Partners's portfolio in Q2 2026, its #42 holding.
- Broadleaf Partners first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
- Broadleaf Partners's Johnson & Johnson position peaked at $1.89M in Q1 2026.
- 4,686 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Broadleaf Partners's 13F filing for Q2 2026, filed 13 Aug 2026.